New UK Biosimilars Pathway Suffers Setback

MHRA Consultation Review Delayed Due To ‘Intense COVID-19 Activities’

 
• By David Wallace
  
Alarm Clock COVID coronavirus
The MHRA’s COVID-19 activities have delayed the new pathway • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products